Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The 2018 Zülch Prize honours research into autoimmunity in neurological diseases. Angela Vincent shares the award with Jerome Posner and Josep Dalmau.

Cancer, infections and other still undescribed factors can trigger the body’s immune system. In some patients’ this results in an autoimmune attack against healthy tissue such as cells of the nervous system that results in a variety of neurological syndromes. This can lead to deficits such as memory loss, seizures, movement disorders, muscle weakness, and psychosis.

The Gertrud Reemtsma Foundation has now paid tribute to Jerome Posner, Angela Vincent and Josep Dalmau for their research into how autoimmunity produces these neurological disorders. Their work has been pivotal in ensuring that many of these disorders are now recognised and patients promptly treated offering the best opportunity for neurologic improvement. In recognition of their outstanding achievement, the researchers have been awarded the Gertrud Reemtsma Foundation's K. J. Zülch Prize worth 50,000 euro. The award ceremony will take place in Cologne, Germany on 21 September 2018.

The prize winners have made crucial advances in research into these immune diseases by providing detailed clinical descriptions and through the development of simple diagnostic tests that allowed practitioners to quickly recognize, diagnose, and treat these patients. Their work has also provided insights into how cancers and other triggers such as viral infections initiate the autoimmune attack. This has opened new avenues to research into how to prevent and optimally treat these diseases. 

Professor Angela Vincent initially studied autoimmune diseases of the peripheral nervous system in which signal transmission between nerves and muscles are impaired. This led her to the then revolutionary insight that certain antibodies can also attack the central nervous system.  She subsequently developed the diagnostic methods widely used in hospitals today.

Read more

Similar stories

Brain immune cells protect neurons in Parkinson’s disease by “nibbling” harmful material

New research, published in Science Translational Medicine, reveals how a specialised population of the brain’s immune cells can remove harmful protein clumps from nerve cells (neurons), pointing to potential new treatments for Parkinson’s disease.

Meeting the neuroscientists at Meeting Minds

Ben Seymour and Masud Husain joined the line up of speakers at this year's Meeting Minds event for Oxford alumni on 19 September

MSc Clinical and Therapeutic Neuroscience Prizes announced, class of 2025/26

Congratulations to all those who have successfully completed the MSc in Clinical and Therapeutic Neuroscience.

Oxford researchers uncover how Parkinson's disease protein damages brain cells

A new study reveals a key mechanism by which the protein alpha-synuclein, the hallmark of Parkinson's disease, damages neurons (brain cells) by blocking a vital cellular gateway. The results of the study, published in Nature Communications, help to explain how the disease begins and highlights a potential new target for treatment.

Silver award for the NDCN Green Impact team

Congratulations to the NDCN Green Impact team who have earned a silver award for their work to improve sustainability within the department.

Celebrating NDCN at Thomas Willis Day 2026

Our annual event where we join together to celebrate our people and the work of our Department over the last year. Nearly 250 staff and students came together for this year's event on Tuesday 16 June at the Mathematical Institute.